Elicio Therapeutics, Inc. Liquidation Value
ELTX
Other
Cash & Equivalents
$18.56M
As of 2025-12-31
Current Price: N/A
Key Metrics
Cash Liquidation Value
Cash minus Total Obligations
Cash: $18.56M
Total Obligations: -$23.21M
$-4.65M
Per share: $-0.26
Period: 2025-12-31
Liquid Liquidation Value
Cash + AR minus Total Obligations
Cash: $18.56M
AR: $0
Total Obligations: -$23.21M
$-4.65M
Per share: $-0.26
Period: 2025-12-31
Operating Liquidation Value
Cash + AR + Inventory minus Total Obligations
Cash: $18.56M
AR: $0
Inventory: $0
Total Obligations: -$23.21M
$-4.65M
Per share: $-0.26
Period: 2025-12-31
Build your own liquidation scenario
Adjust asset discounts and liability assumptions to see how assumptions affect the numbers.
Liquidation Ladder
| Metric | Total | Per Share |
|---|---|---|
| Cash Liquidation Value | $-4.65M | $-0.26 |
| Liquid Liquidation Value | $-4.65M | $-0.26 |
| Operating Liquidation Value | $-4.65M | $-0.26 |
Key Components (as of 2025-12-31)
| Cash & Equivalents | $18.56M |
| Accounts Receivable | N/A |
| Inventory | N/A |
| Current Liabilities | $8.11M |
| Long-term Debt | $10.00M |
| Op. Lease Liability | $5.11M |
| Finance Lease | N/A |
| Shares Outstanding | 17.8M |
Explore all 159 XBRL tags and build your own scenario → Open Calculator
Historical
| Period | Cash | AR | Inventory | AP | Curr Liab | LT Debt | Op Lease | Fin Lease |
|---|---|---|---|---|---|---|---|---|
| 2025-12-31 | $18.56M | N/A | N/A | $672,000 | $8.11M | $10.00M | $5.11M | N/A |
| 2025-09-30 | $20.61M | N/A | N/A | $321,000 | $6.51M | $9.72M | $5.34M | N/A |
| 2025-06-30 | $22.09M | N/A | N/A | $3.87M | $9.92M | $9.34M | $5.57M | N/A |
| 2025-03-31 | $18.35M | N/A | N/A | $4.04M | $11.41M | N/A | $5.79M | N/A |
| 2024-12-31 | $17.62M | N/A | N/A | $1.04M | $11.52M | $20.03M | $6.01M | N/A |
| 2024-09-30 | $26.02M | N/A | N/A | $1.98M | $9.02M | N/A | $6.21M | N/A |
| 2024-06-30 | $3.42M | N/A | N/A | $1.05M | $7.58M | N/A | $6.42M | N/A |
| 2024-03-31 | $11.85M | N/A | N/A | $1.10M | $5.95M | N/A | $6.67M | N/A |
▼ Community Notes